One representative study, which came out yesterday in the New England Journal of Medicine, looked at the persistence of responses through six months following the Moderna vaccine. But there’s every reason to believe that similar results will be seen with the Pfizer, as well as the J&J. If you look at this, antibody activity remained high in all age groups out to 209 days to three serological assays. And I’ll explain in a second what they are.
Next slide.
If you look at this slide — just follow it going from the left to the right — notice that you have here, looking purely at binding antibodies, all age groups from 18 to beyond 71 years of age peaked up. On the bottom of the slide, you’ll see the second arrow at 29 days. It peaked up and stayed up well beyond the 209 days.
END PARTIAL QUOTE FROM:
https://www.whitehouse.gov/briefing-room/press-briefings/2021/04/07/press-briefing-by-white-house-covid-19-response-team-and-public-health-officials-25/
THIS WAS A PART OF THE WHITE HOUSE BRIEFING ON COVID TODAY.
No comments:
Post a Comment